Emmessar Biotech & Nutrition share news, announcements and annual reports
BSE: 524768Chemicals & PetrochemicalsSmall Cap
Emmessar Biotech & Nutrition Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1995
Last close ₹23.63up ₹0.77 (3.37%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹22.86.
30 Oct: open ₹23.59, high ₹23.66, low ₹23.59
52-week range of traded prices to 30 Oct 2026
₹18.42Low, 24 Mar 2026₹33.38High, 20 Nov 2025
- Next results date: the board meets on 31 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹12 Cr4,463rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 29.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.45
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3
Emmessar Biotech & Nutrition share news and announcements
537 announcements, routine notices left out, newest first. Page 2 of 11.
Sep 2024
27 Sep · Meeting
Aug 2024
14 Aug · Results
14 Aug · Board meeting
6 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
Jul 2024
16 Jul · Legal
15 Jul · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on July 15, 2024 with reference to significant movement in price, in order to ensure that investors have latest ....
May 2024
29 May · Results
29 May · Board meeting
14 May · Board meeting
Meeting on 29 May 2024: audited results and quarterly results
Apr 2024
15 Apr · Regulation 7(3) Certificate For Year Ended March 31, 2024
12 Apr · For The Year Ended March 31, 2024
Mar 2024
Feb 2024
27 Feb · Board meeting
Meeting on 20 Mar 202421 Feb · Board meeting
Jan 2024
23 Jan · Board meeting
Meeting on 3 Feb 2024: quarterly results2 Jan · Compliance-57 (5) : intimation after the end of quarter
Dec 2023
Nov 2023
28 Nov · Board meeting
Meeting on 9 Dec 2023: quarterly results
Oct 2023
27 Oct · Board meeting
Meeting on 27 Oct 20233 Oct · Compliance-57 (5) : intimation after the end of quarter
Sep 2023
Aug 2023
Jul 2023
11 Jul · Board meeting
Meeting on 10 Aug 2023: quarterly results4 Jul · Compliance-57 (5) : intimation after the end of quarter
Jun 2023
22 Jun · Announcement under Regulation 30 (LODR)-Demise